HIV Medicine

Cover image for Vol. 18 Issue 10

Edited By: Brian Gazzard and Jens Lundgren

Impact Factor: 3.257

ISI Journal Citation Reports © Ranking: 2016: 26/84 (Infectious Diseases)

Online ISSN: 1468-1293

Most Cited


Read the articles published in 2015 and 2016 which received the most citations in 2016

Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey
E Rosenthal, C Roussillon, D Salmon-Céron, A Georget, S Hénard, T Huleux, I Gueit, E Mortier, D Costagliola, P Morlat, G Chêne, P Cacoub and the Mortalité 2010 and GERMIVIC study groups
Volume 16, Issue 4

Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy
J-P Routy, JB Angel, M Patel, C Kanagaratham, D Radzioch, I Kema, N Gilmore, P Ancuta, J Singer and M-A Jenabian
Volume 16, Issue 1

Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
JD Baxter, D Dunn, E White, S Sharma, AM Geretti, MJ Kozal, MA Johnson, S Jacoby, JM Llibre, J Lundgren and for the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group
Volume 16, Special Issue 1

Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
A Carr, B Grund, J Neuhaus, A Schwartz, JI Bernardino, D White, S Badel-Faesen, A Avihingsanon, K Ensrud, J Hoy and for the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group
Volume 16, Special Issue 1

Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
EJ Wright, B Grund, LA Cysique, KR Robertson, BJ Brew, G Collins, JC Shlay, A Winston, TRH Read, RW Price and for the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group
Volume 16, Special Issue 1

Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons
L Ryom, C Boesecke, V Gisler, C Manzardo, JK Rockstroh, M Puoti, H Furrer, JM Miro, JM Gatell, A Pozniak, G Behrens, M Battegay, JD Lundgren and on behalf of the EACS Governing Board
Volume 17, Issue 2

Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy
M Younas, C Psomas, J Reynes and P Corbeau
Volume 17, Issue 2

HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review
CT Lambert, PB Sandesara, B Hirsh, LJ Shaw, W Lewis, AA Quyyumi, RF Schinazi, WS Post and L Sperling
Volume 17, Issue 6

The ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir
DA Wohl, L Bhatti, CB Small, H Edelstein, HH Zhao, DA Margolis, E DeJesus, WG Weinberg, LL Ross and MS Shaefer
Volume 17, Issue 2

Infection-related and -unrelated malignancies, HIV and the aging population
L Shepherd, ÁH Borges, B Ledergerber, P Domingo, A Castagna, J Rockstroh, B Knysz, J Tomazic, I Karpov, O Kirk, J Lundgren, A Mocroft and on behalf of EuroSIDA in EuroCOORD
Volume 17, Issue 8


FREE - Read the articles published in 2015 which received the most citations in 2015

Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy
Routy, J-P; Angel, J. B.; Patel, M.; Kanagaratham, C.; Radzioch, D.; Kema, I.; Gilmore, N.; Ancuta, P.; Singer, J.; Jenabian, M-A
Volume 16, Issue 1

Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
Baxter, J. D.; Dunn, D.; White, E.; Sharma, S.; Geretti, A. M.; Kozal, M. J.; Johnson, M. A.; Jacoby, S.; Llibre, J. M.; Lundgren, J.
Volume 16, Special Issue 1

Pulmonary function in an international sample of HIV-positive, treatment-naive adults with CD4 counts > 500 cells/mu L: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
Kunisaki, K. M.; Niewoehner, D. E.; Collins, G.; Nixon, D. E.; Tedaldi, E.; Akolo, C.; Kityo, C.; Klinker, H.; La Rosa, A.; Connett, J. E.
Volume 16, Special Issue 1

Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalite 2010 survey
Rosenthal, E.; Roussillon, C.; Salmon-Ceron, D.; Georget, A.; Henard, S.; Huleux, T.; Gueit, I.; Mortier, E.; Costagliola, D.; Morlat, P.; Chene, G.; Cacoub, P.
Volume 16, Issue 4

Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
Carr, A.; Grund, B.; Neuhaus, J.; Schwartz, A.; Bernardino, J. I.; White, D.; Badel-Faesen, S.; Avihingsanon, A.; Ensrud, K.; Hoy, J.
Volume 16, Special Issue 1

Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study
Hoffmann, C.; Hentrich, M.; Gillor, D.; Behrens, G.; Jensen, B.; Stoehr, A.; Esser, S.; van Lunzen, J.; Krznaric, I.; Mueller, M.; Oette, M.; Hensel, M.; Thoden, J.; Faetkenheuer, G.; Wyen, C.
Volume 16, Issue 4

Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses
Crawford, K. W.; Wakabi, S.; Magala, F.; Kibuuka, H.; Liu, M.; Hamm, T. E.
Volume 16, Issue 2

Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study
Gantner, P.; Reinhart, S.; Partisani, M.; Baldeyrou, M.; Batard, M-L; Bernard-Henry, C.; Cheneau, C.; de Mautort, E.; Priester, M.; Fafi-Kremer, S.; Muret, P.; Rey, D.
Volume 16, Issue 2


Articles published in 2012 and 2013 which received the most citations in 2014

British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012
Dr Ian Williams, Dr Duncan Churchill, Prof Jane Anderson et al.
Volume 13, Issue S2

Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis
FM Islam, J Wu, J Jansson, DP Wils
Volume 13, Issue 8

Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
R Weber, M Ruppik, M Rickenbach et al.
Volume 14, Issue 4

Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals
CT Longenecker, NT Funderburg, Y Jiang et al.
Volume 14, Issue 6

British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011
D Asboe, C Aitken, M Boffito et al.
Volume 13, Issue 1

The MONET trial: week 144 analysis of the efficacy of darunavir/ritonavir (DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load < 50 HIV-1 RNA copies/mL at baseline
JR Arribas, N Clumeck, M Nelson et al.
Volume 13, Issue 7

Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial
C Orkin, E De Jesus, H Khanlou et al.
Volume 14, Issue 1

The rate of HIV testing is increasing among men who have sex with men in China
EPF Chow, DP Wilson, L Zhang
Volume 13, Issue 5

HIV testing in community settings in resource-rich countries: a systematic review of the evidence
AC Thornton, V Delpech, MM Kall, A Nardone
Volume 13, Issue 7

Late presentation for HIV diagnosis and care in Germany
A Zoufaly, M an der Heiden, U Marcus et al.
Volume 13, Issue 3

British HIV Association guidelines for the management of HIV infection in pregnant women 2012
Dr GP Taylor, Ms P Clayden, Dr J Dhar et al.
Volume 13, Issue S2

SEARCH

SEARCH BY CITATION